Research / NVT / Fundamental state Inspectable configuration
State dimensions Filing 0001720635-24-000059 General Corporate
Debt relative to revenue 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
288.77% · OPTIONAL · VALID
Capex intensity 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.65% · OPTIONAL · VALID
Operating cash generation 100th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
25.28% · OPTIONAL · VALID
Share-count growth 55th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.shares_outstanding
-0.66% · CORE · VALID
Revenue growth 15th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-8.94% · CORE · VALID
Inventory pressure 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
46.83% · OPTIONAL · VALID
Gross margin 65th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
39.78% · CORE · VALID
Operating margin 75th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
17.03% · CORE · VALID
R&D intensity 25th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.06% · OPTIONAL · VALID
SBC intensity 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.95% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Sep 30, 2021 10/10 normalized Level 3 Dec 31, 2021 10/10 normalized Level 3 Mar 31, 2022 10/10 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 10/10 normalized Level 3 Mar 31, 2023 10/10 normalized Level 3 Jun 30, 2023 10/10 normalized Level 3 Sep 30, 2023 10/10 normalized Level 3 Dec 31, 2023 10/10 normalized Level 3 Mar 31, 2024 10/10 normalized Level 3 Jun 30, 2024 10/10 normalized Level 3 Sep 30, 2024 10/10 normalized Level 3 Dec 31, 2024 10/10 normalized Level 3 Mar 31, 2025 10/10 normalized Level 3 Jun 30, 2025 10/10 normalized Level 3 Sep 30, 2025 10/10 normalized Level 3 Dec 31, 2025 10/10 normalized Level 3 Mar 31, 2026 10/10 normalized Level 3 Jun 30, 2026 10/10 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 200.64%
Current 288.77%
Delta 88.14% Capex Intensity Decreased
Previous 2.10%
Current 1.65%
Delta -0.45% Cash Generation Increased
Previous 14.86%
Current 25.28%
Delta 10.42% Dilution Decreased
Previous 0.27%
Current -0.66%
Delta -0.93% Growth Decreased
Previous 9.63%
Current -8.94%
Delta -18.57% Inventory Pressure Decreased
Previous 50.64%
Current 46.83%
Delta -3.81% Margin Decreased
Previous 41.84%
Current 39.78%
Delta -2.06% Profitability Decreased
Previous 19.06%
Current 17.03%
Delta -2.03% R And D Intensity Decreased
Previous 2.37%
Current 2.06%
Delta -0.32% Sbc Intensity Increased
Previous 0.78%
Current 0.95%
Delta 0.16% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.